These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16385656)

  • 61. Multimodality treatment with radiotherapy for huge hepatocellular carcinoma.
    Han HJ; Kim MS; Cha J; Choi JS; Han KH; Seong J
    Oncology; 2014; 87 Suppl 1():82-9. PubMed ID: 25427738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases.
    Bretagne JF; Raoul JL; Bourguet P; Duvauferrier R; Deugnier Y; Faroux R; Ramée A; Herry JY; Gastard J
    Radiology; 1988 Aug; 168(2):547-50. PubMed ID: 2839867
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effective local control of prostate cancer by intratumoral injection of (166)Ho-chitosan complex (DW-166HC) in rats.
    Kwak C; Hong SK; Seong SK; Ryu JM; Park MS; Lee SE
    Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1400-5. PubMed ID: 16133378
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intracavitary radiation therapy for recurrent cystic brain tumors with holmium-166-chico : a pilot study.
    Ha EJ; Gwak HS; Rhee CH; Youn SM; Choi CW; Cheon GJ
    J Korean Neurosurg Soc; 2013 Sep; 54(3):175-82. PubMed ID: 24278644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cutting edge rare earth radiometals: prospects for cancer theranostics.
    Sadler AWE; Hogan L; Fraser B; Rendina LM
    EJNMMI Radiopharm Chem; 2022 Aug; 7(1):21. PubMed ID: 36018527
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
    Bal CS; Kumar A
    Trop Gastroenterol; 2008; 29(2):62-70. PubMed ID: 18972764
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The various therapeutic applications of the medical isotope holmium-166: a narrative review.
    Klaassen NJM; Arntz MJ; Gil Arranja A; Roosen J; Nijsen JFW
    EJNMMI Radiopharm Chem; 2019 Aug; 4(1):19. PubMed ID: 31659560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A pilot study of trans-arterial injection of 166Holmium-Chitosan complex for treatment of small hepatocellular carcinoma.
    Cho BC; Kim EH; Choi HJ; Kim JH; Roh JK; Chung HC; Ahn JB; Lee JD; Lee JT; Yoo NC; Sohn JH
    Yonsei Med J; 2005 Dec; 46(6):799-805. PubMed ID: 16385656
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Phase II study of transarterial holmium-166-chitosan complex treatment in patients with a single, large hepatocellular carcinoma.
    Sohn JH; Choi HJ; Lee JT; Lee JD; Kim JH; Moon YM; Park K; Park KB; Kim E; Yoo NC
    Oncology; 2009; 76(1):1-9. PubMed ID: 19018149
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.
    Kim JK; Han KH; Lee JT; Paik YH; Ahn SH; Lee JD; Lee KS; Chon CY; Moon YM
    Clin Cancer Res; 2006 Jan; 12(2):543-8. PubMed ID: 16428498
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
    Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
    Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
    Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity.
    Padia SA; Kwan SW; Roudsari B; Monsky WL; Coveler A; Harris WP
    J Vasc Interv Radiol; 2014 Jul; 25(7):1067-73. PubMed ID: 24837982
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.
    Lin SM; Lin CJ; Lin CC; Hsu CW; Chen YC
    Gastroenterology; 2004 Dec; 127(6):1714-23. PubMed ID: 15578509
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Use of Yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis.
    Salem R; Lewandowski R; Roberts C; Goin J; Thurston K; Abouljoud M; Courtney A
    J Vasc Interv Radiol; 2004 Apr; 15(4):335-45. PubMed ID: 15064336
    [TBL] [Abstract][Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.